Delivering the Future of Spatial Pathology

"As the first early access site, we’ve had the chance to appreciate the impact of the very high throughput of the G4X, along with its ability to generate high-quality data across multiple sample types, right from the start. The system’s higher throughput is squarely aligned with current needs of the spatial biology field, where increased sample volumes and lower turnaround-times can enable larger studies, adoption into translational or clinical trial settings, as well as higher return-of-investment and reduced costs for researchers and core facilities”.

"We’re excited to have the G4X in our lab, and the data we’ve seen so far is promising for our work with the Human Tumor Atlas Network. The reproducibility, speed, and cost-efficiency allow us to scale 3D spatial analyses in larger retrospective clinical cohorts. Integrating the high-throughput spatial multimodal analysis of samples on G4X with AI can provide us critical insights into disease mechanisms and therapeutic biomarkers, ultimately advancing patient care.”

“The high sample throughput and the excellent data quality that has been generated on the G4X with our bone marrow samples—notoriously a very difficult tissue type—have been impressive and have allowed us to envision much larger studies that have not been previously possible. The scale provided by the G4X promises to have a tremendous impact on expanding our understanding of the tumor microenvironment in acute myelogenous leukemia (AML) and beyond.”